Almac Diagnostics Opens CLIA Lab to Meet Pharma Partners' Needs
April 05, 2011
Almac Diagnostics Opens CLIA Lab to Meet Pharma Partners' Needs
Almac, headquartered in Craigavon, Northern Ireland, said the new CLIA-registered lab supports its biomarker discovery and development strategy by "enabling the use of novel tests to stratify and enrich prospective clinical trials."
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Affymetrix to Distribute Almac's Xcel Array for Biomarker Discovery
April 3, 2012 / BioArray News - UM Team Partners with Almac Diagnostics to Study Breast Cancer in African-American Women
August 4, 2009 / BioArray News - Dx Firms GenMark, Nanosphere, CombiMatrix Attribute Q1 Revenue Growth to Sales Efforts
May 14, 2013 / BioArray News - Affy Files CytoScan with FDA, Plans 'Aggressive' Marketing Campaign to Grow Cyto Business
February 19, 2013 / BioArray News - After 'Pivotal' 2012, Affy Looks to CytoScan, Axiom Genotyping Products to Drive Future Growth
February 5, 2013 / BioArray News